CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type.
von Sprecher
A
A
Novartis Pharma AG, Basel, Switzerland.
Gerspacher
M
M
Beck
A
A
Anderson
G P
GP
Niederhauser
U
U
Subramanian
N
N
Ball
H A
HA
Gentsch
C
C
Vassout
A
A
Felner
A
A
Bittiger
H
H
Hauser
K
K
Giese
K
K
Kraetz
J
J
Bray
M A
MA
D000085:Acetates / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000494:pharmacology*; D016084:Bronchoconstriction / Q000187:drug effects; D003521:Cyclopropanes; D006168:Guinea Pigs; D007211:Indoles; D020024:Leukotriene Antagonists; D017998:Leukotriene D4 / Q000378:metabolism / Q000494:pharmacology; D008168:Lung / Q000187:drug effects / Q000502:physiology; D015394:Molecular Structure; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D048448:Phenylcarbamates; D011804:Quinolines / Q000737:chemistry / Q000494:pharmacology*; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000494:pharmacology*
D000085:Acetates; D018927:Anti-Asthmatic Agents; C112382:CGP 57698; D003521:Cyclopropanes; D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D011804:Quinolines; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds; D017998:Leukotriene D4; C093875:montelukast; C062735:zafirlukast